UK markets closed

  • FTSE 100

    6,528.41
    +4.05 (+0.06%)
     

  • FTSE 250

    21,010.84
    +14.40 (+0.07%)
     

  • AIM

    1,217.38
    +5.87 (+0.48%)
     

  • GBP/EUR

    1.1394
    -0.0014 (-0.13%)
     

  • GBP/USD

    1.3817
    -0.0011 (-0.08%)
     

  • BTC-GBP

    34,408.64
    +2,382.37 (+7.44%)
     

  • CMC Crypto 200

    964.44
    +51.89 (+5.69%)
     

  • S&P 500

    3,917.60
    +7.72 (+0.20%)
     

  • DOW

    31,442.23
    +4.43 (+0.01%)
     

  • CRUDE OIL

    58.49
    -0.19 (-0.32%)
     

  • GOLD FUTURES

    1,837.10
    -5.60 (-0.30%)
     

  • NIKKEI 225

    29,562.93
    +57.00 (+0.19%)
     

  • HANG SENG

    30,173.57
    +134.85 (+0.45%)
     

  • DAX

    14,038.15
    +105.18 (+0.75%)
     

  • CAC 40

    5,667.20
    -3.60 (-0.06%)
     
LIVE:

DIAL Global Virtual Summit

Join some of the world’s most inspiring and authentic leaders as they dive deep into the key holistic DI&B trends

Akwel: 2020 Turnover Reaches €937.2 Million

Akwel
·4-min read

Thursday 11 February 2021

2020 TURNOVER REACHES €937.2 MILLION

  • Year-on-year decrease limited to -14.9% (-10.9% comparing like-for-like figures.)

  • +4.8% growth in Q4 (+13.6% comparing like-for-like(1))

  • Current operating income for 2020 expected to exceed €100m

AKWEL (FR0000053027, AKW, PEA-eligible), the automotive and HGV equipment and systems manufacturer specialising in fluid management and mechanisms, posted consolidated turnover of €937.2m in 2020, limiting the year-on-year drop to -14.9%, or -10.9% comparing like-for-like figures.

Consolidated turnover (1 January to 31 December)

In € millions - unaudited

2020

2019

Variation

Like-for-like variation(1)

1st half-year

387.1

566.5

-31.7%

-31.0%

3rd quarter

262.0

259.8

+0.9%

+6.7%

4th quarter

288.1

274.9

+4.8%

+13.6%

Total for 12 months

937.2

1,101.2

-14.9%

-10.9%

(1) Comparing like-for-like figures.

RETURN TO GROWTH CONFIRMED IN Q4 OF 2020

After a first half-year highly impacted by the global public health crisis, the recovery that began in September was confirmed in the 4th quarter, with turnover reaching €288.1m, up +4.8%. Comparing like-for-like figures, revenues for the quarter were up +13.6%, taking account of a foreign exchange impact of -€24.0m, including -€17.6m on the Turkish lira and -€5.2m on the US dollar. AKWEL is still outperforming the global automotive market as a whole, which contracted by -0.7% last quarter.

This performance, which was confirmed quarter after quarter in 2020, can be explained by market share gains among the Group’s strategic customers and by buoyant Aftermarket activity, particularly in SCR tanks.

ANALYSIS OF THE BREAKDOWN OF REVENUE

The geographical breakdown of 2020 turnover by production zone was as follows:

  • France: €275.5m (-16.9%)

  • Europe (excluding France) and Africa: €273.3m (-18.5%)

  • North America: €233.2m (-13.5%)

  • Asia and the Middle East (including Turkey): €150.1m (-3.8%)

  • South America: €5.1m (-42.5%)

Despite revenues in all geographical areas being on the wane due to the crisis, three sites clocked up record sales: Paredes de Coura in Portugal, Villieu in France and Chongqing in China.

In line with previous quarters, the Air product family (€87.0) was the strongest performer, with turnover up +8.8% on the same time last year. Despite focusing primarily on diesel, our activities in Decontamination (down 12.8% at €184.0m) and Fuels (down 15.1% at €113.4m) saw only a limited decline in revenue over the year. The Mechanisms product line, meanwhile, fell -13.5% to €125.9m.

Control revenue was down -8.2% at €42.2m, after an unusual 2019.

HIGH FREE CASH FLOW OVER THE YEAR

The Group’s financial situation continued to benefit from the rigorous management and investment control policy adopted before the crisis. AKWEL forecasts free cash flow in excess of €100m over the year and, at the end of December 2020, had net cash flow of nearly €70m, excluding lease debts, with financial debt reduced by €94.2m over the year (-€27.4m in the 4th quarter alone, despite a new €9m payment on account for warranty returns).

BETTER-THAN-EXPECTED PERFORMANCE

Thanks to the commitment of our teams over this demanding period, continued management efforts and sustained activity in the second half-year, the Group’s annual results have improved faster than expected, with a forecast current operating income of more than €100m.

AKWEL finished 2020 with a solid financial situation and bolstered market share. However, the Group remains cautious about its outlook for 2021, in a market that remains low-profile, and is determined to maintain the flexibility and efficiency of its production facilities while investing in order to move with market trends, particularly in clean vehicles.

Next press release: 2020 annual results, 8 April 2021, after the markets close.

An independent, family-owned group listed on the Euronext Paris Stock Exchange, AKWEL is an automotive and HGV equipment and systems manufacturer specialising in fluid management and mechanisms, offering first-rate industrial and technological expertise in applying and processing materials (plastics, rubber, metal) and mechatronic integration.

Operating in 20 countries across every continent, AKWEL employs almost 11,200 people worldwide.



Euronext Paris – Compartment B – ISIN: FR0000053027 – Reuters: AKW.PA – Bloomberg: AKW:FP

Contacts


AKWEL
Jean-Louis Thomasset – Vice-President of the Executive Board/Financial VP – Tel.: +33 4 50 56 99 25

EKNO – Press Relations
Christine Savoie – Jean-Marc Atlan – christine.savoie@ekno.fr – Tel.: +33 6 46 90 34 23 / +33 6 07 37 20 44

CALYPTUS – Investor Relations
Mathieu Calleux – Gregory Bosson – akwel@calyptus.net – Tel.: +33 1 53 65 68 68

Attachment


Latest stories

  • Wallace And Gromit makers and university academics launch mental health campaign

    The ‘What’s up with everyone?’ campaign tackles five of the most common issues negatively impacting young people.

  • Universal Electronics Inc. Introduces UEI Comfort Family of Connected Thermostats

    Universal Electronics Inc. (UEI) (NASDAQ: UEIC), the global leader in universal control and sensing technologies for the smart home, is introducing the UEI Comfort family of connected thermostats designed to simplify installation, daily use and ongoing support of climate control in residential, commercial and hospitality applications. UEI has more than 20 years of experience providing end-to-end advanced control solutions to the world’s leading HVAC brands.

  • Ad•Altimetry

    Why don't you like this ad?

    Thank you for your feedback. We will remove this and make the necessary changes.

    Man Who Said to Buy AMD at $2.67 Has New Message

    Joel Litman predicted the March 2020 crash… And the bull market that followed. Now, he says this new trend will fuel the 5 tech giants of the 2020s.

  • Two in five top universities in UK see drop in students from state schools

    The figures come as institutions are under increasing pressure from ministers to widen access to higher education.

  • Global Breach and Attack Simulation 2020 Market - Featuring BitDam, Cymulate and Mandiant Solutions Among Others - ResearchAndMarkets.com

    The "Global Breach and Attack Simulation Market, 2020 - Frost Radar Report" report has been added to ResearchAndMarkets.com's offering.

  • United Kingdom Conveyancing Market Report 2020: Consolidation, COVID-19, Concerns for Conveyancers in 2020-2021 - ResearchAndMarkets.com

    The "UK Conveyancing Market Report 2020" report has been added to ResearchAndMarkets.com's offering.

  • Ad•Empire Financial Research

    Why don't you like this ad?

    Thank you for your feedback. We will remove this and make the necessary changes.

    Man Who Bought Netflix at $7.78 Says Buy This Now

    Wall Street legend Whitney Tilson says there's a huge new tech trend coming – and he's giving away his top pick for free right here.

  • Portuguese referee gets death threats after two red cards

    Godinho dismissed Porto duo Luis Diaz and Matheus Uribe in the Taca de Portugal semi-final, first leg. The game was marred by a serious injury to Braga's David Carmo, which caused a lengthy stoppage after the ambulance broke down and had to be pushed from the field by players.

  • 'Amazing' noise-cancelling headphones have more than 4,400 reviews - and they're on sale for just $56

    "I can't believe I didn't discover this brand sooner."

  • Landsbankinn hf.: Financial results of Landsbankinn for 2020

    Landsbankinn's after-tax profit in 2020 was ISK 10.5 billion.Return on equity (ROE) was 4.3% in 2020, as compared with 7.5% in 2019. The Bank’s target is 10% minimum ROE. Return on equity (ROE) was 15.5% in Q4 2020 as compared with 6,3% for the same period the previous year.The cost-income ratio grew between years, was 47.4% in 2020 as compared with 42.6% in 2019.Landsbankinn’s credit portfolio grew by ISK 133.2 billion. The default ratio at year-end 2020 was 0.8%, the same number as at year-end 2019. Landsbankinn's equity amounted to ISK 258.3 billion at year-end 2020 and its capital ratio was 25.1% of risk-weighted assets.A proposal will be made to the AGM to pay an ISK 4.5 billion dividend to shareholders for the year 2020, the equivalent of ISK 0.19 per share.Landsbankinn's annual and ESG report, and Pillar III risk report for 2020 are published alongside its Annual Financial Statements. The profit of Landsbankinn hf. in 2020 was ISK 10.5 billion after taxes, as compared with ISK 18.2 billion in 2019. After-tax ROE was 4.3% in 2020, as compared with 7.5% in 2018. Net interest income amounted to ISK 38.1 billion in 2020, as compared with ISK 39.7 billion in 2018. Landsbankinn's net fee and commission income was ISK 7.6 billion in 2020, as compared with ISK 8.2 billion in 2019. Other operating income was negative by ISK 7.5 billion in 2020, as compared with ISK 3.6 billion in 2019. The decrease is mainly the result of an ISK 12 billion impairment of financial assets as compared with impairment in the amount of ISK 4.8 billion in 2019. Increased impairment of financial assets is more or less directly attributable to Covid-19. Total defaults by corporates and households remained stable between years at 0.8%. Temporary Covid-19 relief measures led to lower values for loans 90 days in arrears. The Bank's operating profit for 2020 amounted to ISK 38.3 billion, as compared to ISK 51.5 billion the previous year. The net interest margin on assets and liabilities was 2.5% as compared with 2.8% the previous year. Operating expenses amounted to ISK 25.6 billion in 2020, as compared with ISK 28.2 billion in 2019. Wages and related expenses amounted to ISK 14.8 billion as compared with ISK 14.5 billion the previous year. Other operating expenses were ISK 9.1 billion in 2020, as compared with ISK 9.5 billion in 2019. Pre-tax profit in 2020 amounted to ISK 12.6 billion, as compared with ISK 23.3 billion in 2019. Imputed taxes, including a special financial management tax on wages, amount to ISK 4.6 billion in 2020 as compared with ISK 10 billion in 2019. Landsbankinn's total assets grew by ISK 137.8 billion between years and amounted to ISK 1,564 billion at year-end 2020. Lending increased by 12% between years, or by just over ISK 133 billion. The growth in lending is due mostly to an increase in loans to private persons. At the end of 2020, deposits from customers amounted to ISK 793 billion as compared with ISK 708 billion at year-end 2019. Landsbankinn’s equity at year-end 2020 was ISK 258.3 billion, as compared with ISK 247.7 billion at year-end 2019. No dividend was paid to shareholders in 2020. Landsbankinn’s CAR at year-end 2020 was 25.1%, as compared with 25.8% at year-end 2019. The Financial Supervisory Authority of the Central Bank of Iceland (FSA), sets Landsbankinn’s total capital requirement at 18.8%. The Board of Directors of Landsbankinn will propose to the AGM on 24 March 2021 that shareholders be paid a dividend of ISK 0.19 per share for the year 2020, a total amount of ISK 4.5 billion. The dividend is equivalent to 43% of the Group’s 2020 profit. Lilja Björk Einarsdóttir, CEO of Landsbankinn: “The 2020 results are a reflection of sound, effective and stable operations. The Bank’s profit in 2020 was ISK 10.5 billion, ROE was 4.3% for the year and the Bank’s performance was good across the entire operation. Results were good, especially bearing in mind that the Bank made an ISK 12 billion provision for loan impairment, largely to cover the possibility of a credit loss that has not materialised. These results demonstrate that the Bank is strongly placed to support the economic recovery as well as to support customers who have suffered a significant loss of income as a consequence of the pandemic. Emphasis on operational efficiencies have helped to keep costs stable. The cost-income ratio changes slightly and was 47.7% for the year 2020. Operating costs remained more or less the same, as has been the case for several years. At the same time, we are investing a great deal in digital development. Over the past three years, the Bank has introduced around 40 innovative digital solutions to customers. Never before has Landsbankinn granted more mortgages, both for buyers as well as for refinancing purposes. The Bank lowered interest rates six times and, despite significant challenges associated with the pandemic, we were able to meet a significant increase in demand for mortgages and ensure very good and competitive terms for our customers. Over 10,000 individuals and families took out a mortgage with us in 2020 and the Bank’s overall share in the mortgage market grew to 26.3%. My first thoughts are expressing gratitude to our loyal customers for their business in a year where all previous plans were turned upside down. We provide customers around the country with financial services, including around 700 companies in the travel sector. We have supported our customers, providing moratorium and assistance, and we all hope to see economic recovery in the autumn. The Bank’s employees have risen to the challenge, showing a great deal of resourcefulness and adaptability. We maintained virtually unchanged service levels through our robust digital service platform, supported by our excellent staff. Customers responded well to the changes in service and were quick to adopt new solutions, they knew that Landsbankinn was there for them. In 2021, Landsbankinn will operate under a new strategy - Landsbankinn, an ever-smarter bank. Our enthusiastic engagement with new technology is fuelled by our drive to achieve success, which strengthens operations and boosts initiative. Our aim is to simplify the life for our customers. We kick off the year with the publication of a new sustainable finance framework and intend to continue to lead the field in sustainability. That’s Landsbankinn, an ever-smarter bank.” Teleconference to present results On Friday 12 February, at 10:00, the Bank will host a teleconference on its results in English. Please register by email to ir@landsbankinn.is. Landsbankinn's financial calendar Annual General Meeting, 24 March 2021 Q1 2021 results 6 May 2021 Q2 2021 results 22 July 2021 Q3 2021 results 28 October 2021 Annual Results 2021 3 February 2022 For further information contact: Rúnar Pálmason, Public Relations, pr@landsbankinn.is Hanna Kristín Thoroddsen, Investor Relations, ir@landsbankinn.is Attachments Landsbankinn Consolidated Financial Statements 2020 Pillar III risk report 2020 Results presentation Landsbankinn financial year 2020 Press release Landsbankinn financial year 2020

  • Ad•USA News Group

    Why don't you like this ad?

    Thank you for your feedback. We will remove this and make the necessary changes.

    Gold Alert: Massive 2021 Opportunity In Gold Stock

    U.S. stimulus to trigger rally: Gold price to surge to $2,200 by year-end. Those who invest wisely could stand to make a fortune from the rally.....

  • The Many, Many Face Masks Of Nancy Pelosi

    The speaker of the House's face covering collection is unparalleled.

  • Guerbet: Revenue 2020

    2020 revenue Revenue in line with forecasts despite the health crisis -12.8% at current exchange rates at €712.3 million -10.0% at constant exchange rates (CER) 1 at €735.4 million Villepinte, February 11, 2021 – Guerbet (FR0000032526), a global specialist in contrast agents and solutions for medical imaging, today reported its revenue for 2020. The financial year was marked by the health crisis. The postponement of some examinations and non-essential radiological procedures had a significant impact on activity, resulting in a contraction of the market. As of December 31, 2020, reported revenue was €712.3 million, down 12.8% from December 31, 2019, including a substantial forex impact of €23.1 million. Revenue at constant exchange rates (CER) was down 10.0% at €735.4 million, as the Group expected. Consolidated Group revenue (IFRS) In millions of euros,at December 31, 2020Change (%) 2020at current exchange rates Change (%) 2020at constant exchange rates* Reported 2019 Sales in Europe-15.9%290.3-15.4%292.0345.2Sales in Other Markets-10.5%422.0-6.0%443.4471.7Total-12.8%712.3-10.0%735.4816.9 [1] At constant exchange rates: amounts and rates of growth are calculated by canceling out the forex impact, which is defined as the difference between the indicator's value for period N, converted at the exchange rate for period N-1, and the indicator's value for periodN-1. In Europe, annual revenue at constant exchange rates totaled €292.0 million, down 15.4%. After a first half of the year down 21.2% at constant exchange rates and a third quarter down 5.7%, the fourth quarter suffered from an even worse health situation, resulting in a 12.6% decline. In the Americas, on a like-for-like basis1, sales at constant exchange rates were down slightly (-1.9%) in the fourth quarter, compared with the decline of slightly less than 20% in the third quarter. This good resistance came from the North America region, where the number of imaging procedures began to rebound at the end of 2020. Over the financial year, on a like-for-like basis and excluding an adverse forex impact of €18.4 million attributable to the weakened Brazilian real and US dollar, the decline in activity in the Americas was 12.0% at constant exchange rates for revenues of €225.4 million. In Asia, total revenue at constant exchange rates for the financial year increased +2.2% to €168.8 million (+1.0% at current exchange rates). After a good performance in the first nine months of the year, activity was down in the fourth quarter due to a base effect in China and COVID-19 crisis in Korea. Analysis by activity: Diagnostic Imaging revenue totaled €637.2 million, compared with €719.4 million at December 31, 2019, down 11.4% at constant exchange rates (-14.5% at €615.2 million at current exchange rates). MRI sales decreased 15.3% at constant exchange rates (-17.2% at current exchange rates) at €232.8 million. This decline was due to a negative volume effect directly related to the health crisis and, to a lesser extent, an adverse price effect in Europe related to the generic form of Dotarem®. X-ray revenue at constant exchange rates totaled €402 million, down 8.8% (-12.6% at current exchange rates), with Xenetix® showing good resistance throughout the year. Interventional Imaging was down slightly at -1.5% at constant exchange rates (-2.7% at current exchange rates), still driven by Lipiodol® with sales up nearly 1% at constant exchange rates. The segment's revenue totaled €74.4 million, compared with €75.5 million in 2019. Outlook Guerbet is maintaining the objectives reported with its half-year results. The Group's projected EBITDA margin for the 2020 financial year is around 14% of revenue, thanks in particular to the strict management of structural costs, which should have a positive impact on profitability once activity returns to normal. For 2021, the course of the health situation remains uncertain. Over the coming months, the Group still anticipates the arrival of the generic form of Dotarem® in the United States. The Group expects the impact to be moderate with changes in Dotarem® prices comparable with Europe, where the generic form as already been available for more than two years. Upcoming events: Publication of 2020 annual resultsMarch 24, 2021, after trading About Guerbet Guerbet is a leader in medical imaging worldwide, offering a comprehensive range of pharmaceutical products, medical devices, and digital and AI solutions for diagnostic and interventional imaging to improve patient diagnosis and treatment. A pioneer in contrast media for more than 90 years, with more than 2,600 employees worldwide, Guerbet continuously innovates and devotes 9% of its sales to research and development in four centers in France, Israel, and the United States. Guerbet (GBT) is listed on Euronext Paris (segment B – mid caps) and generated €712 million in revenue in 2020. For more information about Guerbet, please visit (www.guerbet.com). Forward-looking statements Certain information contained in this press release does not reflect historical data but constitutes forward-looking statements. These forward-looking statements are based on estimates, forecasts, and assumptions, including but not limited to assumptions about the current and future strategy of the Group and the economic environment in which the Group operates. They involve known and unknown risks, uncertainties, and other factors that may result in a significant difference between the Group's actual performance and results and those presented explicitly or implicitly by these forward-looking statements. These forward-looking statements are valid only as of the date of this press release, and the Group expressly disclaims any obligation or commitment to publish an update or revision of the forward-looking statements contained in this press release to reflect changes in their underlying assumptions, events, conditions, or circumstances. The forward-looking statements contained in this press release are for illustrative purposes only. Forward-looking statements and information are not guarantees of future performance and are subject to risks and uncertainties that are difficult to predict and are generally beyond the Group's control. These risks and uncertainties include but are not limited to the uncertainties inherent in research and development, future clinical data and analyses (including after a marketing authorization is granted), decisions by regulatory authorities (such as the US Food and Drug Administration or the European Medicines Agency) regarding whether and when to approve any application for a drug, process, or biological product filed for any such product candidates, as well as their decisions regarding labeling and other factors that may affect the availability or commercial potential of such product candidates. A detailed description of the risks and uncertainties related to the Group's activities can be found in Chapter 4.8 "Management and risk factors" of the Group's Universal Registration Document filed with the AMF (French financial markets authority) under number D-20-0369 on April 28, 2020, available on the Group's website (www.guerbet.com). For more information about Guerbet, please visit www.guerbet.com Contacts GuerbetActifinJérôme EstampesChief Financial Officer01 45 91 50 00 Financial CommunicationsBenjamin Lehari01 56 88 11 25blehari@actifin.fr PressJennifer Jullia01 56 88 11 19jjullia@actifin.fr 1 Excluding the subcontracting activity following the sale of the Montreal plant in Canada in July 2020 Attachment Guerbet CP CA T4 2020_EN VFinale

  • Lacroix Group : LACROIX Group confirms healthy end-of-year momentum.

    LACROIX Group confirms healthy end-of-year momentum LACROIX Group (LACR - FR0000066607), an international technological equipment manufacturer, has announced its revenue for the fifth quarter of its 2019-2020 financial year. As a reminder, following the change in balance sheet date, the current financial year had an exceptional duration of 15 months (from 1 October 2019 to 31 December 2020), i.e. five distinct quarters. Therefore, for the purpose of comparison, the 5th quarter of the 2019-2020 fiscal year should be compared to the 1st quarter of the same fiscal year (October-December 2019). This press release also includes revenue information compiled on a 12-month pro-forma basis (from 1 January to 31 December) in order to be consistent with the new fiscal year period. Healthy momentum which confirms the turnaround since the 4th quarter In the 5th quarter (October-December 2020), LACROIX Group recorded revenue of €128.1m, up 2.2% compared with the comparable period, i.e. October-December 2019. This performance confirms the gradual return to growth observed from the previous quarter onwards (+1.8% compared to July-September 2019), despite a second national lockdown and strong growth recorded in the comparable period (+7.6% in the 1st quarter). On a like-for-like basis, growth in the 5th quarter was 1.6%. Revenuer in euros millions2019/20202018/2019ChangeCumulative total2019/2020Cumulative total2018/2019Change1st quarter125.4116.5 +7.6%125.4116.5+7.6%2nd quarter113.4122.6-7.5%238.8239.0-0.1%3rd quarter80.1125.4-36.1%318.9364.4-12.5%4th quarter 119.4117.3+1.8%438.3481.7-9.0%5th quarter 128.1 +2.2%566.3 +17.6%Total LACROIX Group566.3 481.7 17.6%566.3481.7 +17.6% For the full financial year (15 months, from 1 October 2019 to 31 December 2020), the Group generated revenue of €566.3m, up 17.6% on a published data basis. On a pro forma 12-month basis (from January 1 to December 31, 2020), revenue fell 10.1% to €441.0m, down from €490.5m. A turnaround driven by all the Group's operations In the 5th quarter (October-December) alone, the return to growth observed in the previous quarter was confirmed. Revenue in euros millionsQ5 2019/2020(Oct – Dec 20)Q1 2019/2020(Oct – Dec 19)ChangeCumulative total2019/2020(Oct 19 – Dec 20)15 monthsCumulative total2018/2019(Oct 18 – Sept 19)12 monthsChangeLACROIX Electronics79.279.9 -0.8%355.2317.7+11.8%LACROIX City29.227.2+7.3%125.3104.6+19.8%LACROIX Environment 19.718.3+7.6%85.859.2+44.9%Total LACROIX Group128.1 125.4+2.2%566.3481.7 +17.6% Over the period, LACROIX Electronics recorded relatively stable revenue of €79.2m, compared with €79.9m in the 1st quarter. This stability conceals strong underlying performance, given on the one hand the difficulties of the aeronautics sector due to the pandemic, and on the other hand, a strong 1st comparable quarter (+5.8% over the period for the Electronics business). On a like-for-like basis, LACROIX Electronics recorded a slight fall of 1.9% over the quarter. On a 12-month pro forma basis, revenue fell by 14.5%. While LACROIX City had already recorded a return to growth in the 4th quarter (+0.4%), the 5th quarter saw a marked improvement in trading, with revenue of €29.2m, up 7.3% compared with the 1st quarter, both on published data and like-for-like basis. Over the period, the renewed growth was mainly driven by a catch-up effect in the road signs segment and strong growth in the Traffic Management segment. On a 12-month pro forma basis, LACROIX City recorded a 5.8% fall in revenue. After a strong catch-up in the 4th quarter, the LACROIX Environment business continued its excellent growth in the 5th quarter with 7.6% revenue growth up to €19.7m, compared with the same period the previous year. Growth was driven in particular by the Smart Grid segment (26.0% quarterly growth). On a 12-month pro forma basis, revenue increased by 5.1%. "After an incomparable financial year in many ways, whether with regard to the impact of the pandemic or the change in our fiscal year period, LACROIX Group ended the year on a very satisfactory note, which is a testament to the strong resilience of our model. With the prospect of a forthcoming end to this crisis and despite the caution imposed by this unprecedented period, we are particularly confident in our ability to quickly return onto the path to growth and to incorporate this into the ambitious strategic plan that we will unveil in April.” concluded Vincent Bedouin, Chairman and CEO of LACROIX Group. Outlook The marked recovery in trading in the 4th and 5th quarters will be positively reflected in the results for the 2019-2020 financial year. 2021 will be a pivotal year for the Group, with the unveiling of the strategic plan that will underpin the Group’s development for the next five years, the detailed themes of which will be unveiled on 7 April. Upcoming dates 2019/2020 annual results (15 months): 25 March 2021 after market close ABOUT LACROIX Group LACROIX Group is an international technological equipment manufacturer, aiming to serve a connected and responsible world with its technical and industrial excellence. As a listed family-run mid-cap, LACROIX Group combines the essential agility required to innovate in an ever-changing technological sector with the industrial capacity to produce robust, secure equipment and the long-term vision to invest and build for the future. LACROIX Group designs and produces its customers’ electronic equipment, in particular in the automotive, home automation, aeronautical, industrial and health sectors. LACROIX Group also provides safe, connected equipment for the management of critical infrastructures such as smart roads (street lighting, traffic signs, traffic management, V2X) and the management and operation of water and energy systems. Drawing on its extensive experience and expertise, the Group works with its customers and partners to build the connection between the world of today and the world of tomorrow. It helps them to create the industry of the future and to make the most of the opportunities for innovation that surround them, supplying them with the equipment for a smarter world. Find our financial data in our Investor areahttps://www.lacroix-group.com/investors/ Contacts LACROIX GroupCOO & Executive Vice-President Finance Nicolas Bedouininfo@lacroix-group.comTel.: +33 (0)2 40 92 58 56ACTIFINPress relationsJennifer Jullia jjullia@actifin.frTel.: +33 (0)1 56 88 11 19ACTIFINFinancial communicationSimon Derbannesderbanne@actifin.frTel.: +33 (0)1 56 88 11 14 Attachment LACROIX_PR_revenue_Q5_20210211_EN_vdef

  • Ad•The Motley Fool

    Why don't you like this ad?

    Thank you for your feedback. We will remove this and make the necessary changes.

    Motley Fool Issues Rare “All In” Buy Alert

    It’s rare that David and Tom formally agree on the exact same stock – it’s only happened 25 times over the entire history of Motley Fool Stock Advisor

  • Global Laboratory Analytical Instruments and Consumables Industry

    Global Laboratory Analytical Instruments and Consumables Market to Reach $50. 9 Billion by 2027. Amid the COVID-19 crisis, the global market for Laboratory Analytical Instruments and Consumables estimated at US$36.New York, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Laboratory Analytical Instruments and Consumables Industry" - https://www.reportlinker.com/p05957208/?utm_source=GNW 5 Billion in the year 2020, is projected to reach a revised size of US$50.9 Billion by 2027, growing at a CAGR of 4.9% over the analysis period 2020-2027. Element Analysis, one of the segments analyzed in the report, is projected to record a 5.1% CAGR and reach US$19.4 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Separation Analysis segment is readjusted to a revised 4.3% CAGR for the next 7-year period. The U.S. Market is Estimated at $9.9 Billion, While China is Forecast to Grow at 7.5% CAGR The Laboratory Analytical Instruments and Consumables market in the U.S. is estimated at US$9.9 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$10.4 Billion by the year 2027 trailing a CAGR of 7.5% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.7% and 4.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3% CAGR. Molecular Analysis Segment to Record 5.1% CAGR In the global Molecular Analysis segment, USA, Canada, Japan, China and Europe will drive the 4.7% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$8 Billion in the year 2020 will reach a projected size of US$11 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$6.8 Billion by the year 2027, while Latin America will expand at a 6.2% CAGR through the analysis period. We bring years of research experience to this 7th edition of our report. The 179-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed. Competitors identified in this market include, among others, Agilent Technologies, Inc.Bruker CorporationDanaher CorporationHoriba Ltd.PerkinElmer, Inc. Read the full report: https://www.reportlinker.com/p05957208/?utm_source=GNW I. INTRODUCTION, METHODOLOGY & REPORT SCOPE II. EXECUTIVE SUMMARY 1. MARKET OVERVIEW Global Competitor Market Shares Laboratory Analytical Instruments and Consumables Competitor Market Share Scenario Worldwide (in %): 2019 & 2025 Impact of Covid-19 and a Looming Global Recession 2. FOCUS ON SELECT PLAYERS 3. MARKET TRENDS & DRIVERS 4. GLOBAL MARKET PERSPECTIVE Table 1: World Current & Future Analysis for Laboratory Analytical Instruments and Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 Table 2: World Historic Review for Laboratory Analytical Instruments and Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 3: World 15-Year Perspective for Laboratory Analytical Instruments and Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027 Table 4: World Current & Future Analysis for Element Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 Table 5: World Historic Review for Element Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 6: World 15-Year Perspective for Element Analysis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 7: World Current & Future Analysis for Separation Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 Table 8: World Historic Review for Separation Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 9: World 15-Year Perspective for Separation Analysis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 10: World Current & Future Analysis for Molecular Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 Table 11: World Historic Review for Molecular Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 12: World 15-Year Perspective for Molecular Analysis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 III. MARKET ANALYSIS GEOGRAPHIC MARKET ANALYSIS UNITED STATES Market Facts & Figures US Laboratory Analytical Instruments and Consumables Market Share (in %) by Company: 2019 & 2025 Market Analytics Table 13: USA Current & Future Analysis for Laboratory Analytical Instruments and Consumables by End-Use - Element Analysis, Separation Analysis and Molecular Analysis - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 Table 14: USA Historic Review for Laboratory Analytical Instruments and Consumables by End-Use - Element Analysis, Separation Analysis and Molecular Analysis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 15: USA 15-Year Perspective for Laboratory Analytical Instruments and Consumables by End-Use - Percentage Breakdown of Value Sales for Element Analysis, Separation Analysis and Molecular Analysis for the Years 2012, 2020 & 2027 CANADA Table 16: Canada Current & Future Analysis for Laboratory Analytical Instruments and Consumables by End-Use - Element Analysis, Separation Analysis and Molecular Analysis - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 Table 17: Canada Historic Review for Laboratory Analytical Instruments and Consumables by End-Use - Element Analysis, Separation Analysis and Molecular Analysis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 18: Canada 15-Year Perspective for Laboratory Analytical Instruments and Consumables by End-Use - Percentage Breakdown of Value Sales for Element Analysis, Separation Analysis and Molecular Analysis for the Years 2012, 2020 & 2027 JAPAN Table 19: Japan Current & Future Analysis for Laboratory Analytical Instruments and Consumables by End-Use - Element Analysis, Separation Analysis and Molecular Analysis - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 Table 20: Japan Historic Review for Laboratory Analytical Instruments and Consumables by End-Use - Element Analysis, Separation Analysis and Molecular Analysis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 21: Japan 15-Year Perspective for Laboratory Analytical Instruments and Consumables by End-Use - Percentage Breakdown of Value Sales for Element Analysis, Separation Analysis and Molecular Analysis for the Years 2012, 2020 & 2027 CHINA Table 22: China Current & Future Analysis for Laboratory Analytical Instruments and Consumables by End-Use - Element Analysis, Separation Analysis and Molecular Analysis - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 Table 23: China Historic Review for Laboratory Analytical Instruments and Consumables by End-Use - Element Analysis, Separation Analysis and Molecular Analysis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 24: China 15-Year Perspective for Laboratory Analytical Instruments and Consumables by End-Use - Percentage Breakdown of Value Sales for Element Analysis, Separation Analysis and Molecular Analysis for the Years 2012, 2020 & 2027 EUROPE Market Facts & Figures European Laboratory Analytical Instruments and Consumables Market: Competitor Market Share Scenario (in %) for 2019 & 2025 Market Analytics Table 25: Europe Current & Future Analysis for Laboratory Analytical Instruments and Consumables by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 Table 26: Europe Historic Review for Laboratory Analytical Instruments and Consumables by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 27: Europe 15-Year Perspective for Laboratory Analytical Instruments and Consumables by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027 Table 28: Europe Current & Future Analysis for Laboratory Analytical Instruments and Consumables by End-Use - Element Analysis, Separation Analysis and Molecular Analysis - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 Table 29: Europe Historic Review for Laboratory Analytical Instruments and Consumables by End-Use - Element Analysis, Separation Analysis and Molecular Analysis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 30: Europe 15-Year Perspective for Laboratory Analytical Instruments and Consumables by End-Use - Percentage Breakdown of Value Sales for Element Analysis, Separation Analysis and Molecular Analysis for the Years 2012, 2020 & 2027 FRANCE Table 31: France Current & Future Analysis for Laboratory Analytical Instruments and Consumables by End-Use - Element Analysis, Separation Analysis and Molecular Analysis - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 Table 32: France Historic Review for Laboratory Analytical Instruments and Consumables by End-Use - Element Analysis, Separation Analysis and Molecular Analysis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 33: France 15-Year Perspective for Laboratory Analytical Instruments and Consumables by End-Use - Percentage Breakdown of Value Sales for Element Analysis, Separation Analysis and Molecular Analysis for the Years 2012, 2020 & 2027 GERMANY Table 34: Germany Current & Future Analysis for Laboratory Analytical Instruments and Consumables by End-Use - Element Analysis, Separation Analysis and Molecular Analysis - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 Table 35: Germany Historic Review for Laboratory Analytical Instruments and Consumables by End-Use - Element Analysis, Separation Analysis and Molecular Analysis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 36: Germany 15-Year Perspective for Laboratory Analytical Instruments and Consumables by End-Use - Percentage Breakdown of Value Sales for Element Analysis, Separation Analysis and Molecular Analysis for the Years 2012, 2020 & 2027 ITALY Table 37: Italy Current & Future Analysis for Laboratory Analytical Instruments and Consumables by End-Use - Element Analysis, Separation Analysis and Molecular Analysis - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 Table 38: Italy Historic Review for Laboratory Analytical Instruments and Consumables by End-Use - Element Analysis, Separation Analysis and Molecular Analysis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 39: Italy 15-Year Perspective for Laboratory Analytical Instruments and Consumables by End-Use - Percentage Breakdown of Value Sales for Element Analysis, Separation Analysis and Molecular Analysis for the Years 2012, 2020 & 2027 UNITED KINGDOM Table 40: UK Current & Future Analysis for Laboratory Analytical Instruments and Consumables by End-Use - Element Analysis, Separation Analysis and Molecular Analysis - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 Table 41: UK Historic Review for Laboratory Analytical Instruments and Consumables by End-Use - Element Analysis, Separation Analysis and Molecular Analysis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 42: UK 15-Year Perspective for Laboratory Analytical Instruments and Consumables by End-Use - Percentage Breakdown of Value Sales for Element Analysis, Separation Analysis and Molecular Analysis for the Years 2012, 2020 & 2027 SPAIN Table 43: Spain Current & Future Analysis for Laboratory Analytical Instruments and Consumables by End-Use - Element Analysis, Separation Analysis and Molecular Analysis - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 Table 44: Spain Historic Review for Laboratory Analytical Instruments and Consumables by End-Use - Element Analysis, Separation Analysis and Molecular Analysis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 45: Spain 15-Year Perspective for Laboratory Analytical Instruments and Consumables by End-Use - Percentage Breakdown of Value Sales for Element Analysis, Separation Analysis and Molecular Analysis for the Years 2012, 2020 & 2027 RUSSIA Table 46: Russia Current & Future Analysis for Laboratory Analytical Instruments and Consumables by End-Use - Element Analysis, Separation Analysis and Molecular Analysis - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 Table 47: Russia Historic Review for Laboratory Analytical Instruments and Consumables by End-Use - Element Analysis, Separation Analysis and Molecular Analysis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 48: Russia 15-Year Perspective for Laboratory Analytical Instruments and Consumables by End-Use - Percentage Breakdown of Value Sales for Element Analysis, Separation Analysis and Molecular Analysis for the Years 2012, 2020 & 2027 REST OF EUROPE Table 49: Rest of Europe Current & Future Analysis for Laboratory Analytical Instruments and Consumables by End-Use - Element Analysis, Separation Analysis and Molecular Analysis - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 Table 50: Rest of Europe Historic Review for Laboratory Analytical Instruments and Consumables by End-Use - Element Analysis, Separation Analysis and Molecular Analysis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 51: Rest of Europe 15-Year Perspective for Laboratory Analytical Instruments and Consumables by End-Use - Percentage Breakdown of Value Sales for Element Analysis, Separation Analysis and Molecular Analysis for the Years 2012, 2020 & 2027 ASIA-PACIFIC Table 52: Asia-Pacific Current & Future Analysis for Laboratory Analytical Instruments and Consumables by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 Table 53: Asia-Pacific Historic Review for Laboratory Analytical Instruments and Consumables by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 54: Asia-Pacific 15-Year Perspective for Laboratory Analytical Instruments and Consumables by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2020 & 2027 Table 55: Asia-Pacific Current & Future Analysis for Laboratory Analytical Instruments and Consumables by End-Use - Element Analysis, Separation Analysis and Molecular Analysis - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 Table 56: Asia-Pacific Historic Review for Laboratory Analytical Instruments and Consumables by End-Use - Element Analysis, Separation Analysis and Molecular Analysis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 57: Asia-Pacific 15-Year Perspective for Laboratory Analytical Instruments and Consumables by End-Use - Percentage Breakdown of Value Sales for Element Analysis, Separation Analysis and Molecular Analysis for the Years 2012, 2020 & 2027 AUSTRALIA Table 58: Australia Current & Future Analysis for Laboratory Analytical Instruments and Consumables by End-Use - Element Analysis, Separation Analysis and Molecular Analysis - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 Table 59: Australia Historic Review for Laboratory Analytical Instruments and Consumables by End-Use - Element Analysis, Separation Analysis and Molecular Analysis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 60: Australia 15-Year Perspective for Laboratory Analytical Instruments and Consumables by End-Use - Percentage Breakdown of Value Sales for Element Analysis, Separation Analysis and Molecular Analysis for the Years 2012, 2020 & 2027 INDIA Table 61: India Current & Future Analysis for Laboratory Analytical Instruments and Consumables by End-Use - Element Analysis, Separation Analysis and Molecular Analysis - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 Table 62: India Historic Review for Laboratory Analytical Instruments and Consumables by End-Use - Element Analysis, Separation Analysis and Molecular Analysis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 63: India 15-Year Perspective for Laboratory Analytical Instruments and Consumables by End-Use - Percentage Breakdown of Value Sales for Element Analysis, Separation Analysis and Molecular Analysis for the Years 2012, 2020 & 2027 SOUTH KOREA Table 64: South Korea Current & Future Analysis for Laboratory Analytical Instruments and Consumables by End-Use - Element Analysis, Separation Analysis and Molecular Analysis - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 Table 65: South Korea Historic Review for Laboratory Analytical Instruments and Consumables by End-Use - Element Analysis, Separation Analysis and Molecular Analysis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 66: South Korea 15-Year Perspective for Laboratory Analytical Instruments and Consumables by End-Use - Percentage Breakdown of Value Sales for Element Analysis, Separation Analysis and Molecular Analysis for the Years 2012, 2020 & 2027 REST OF ASIA-PACIFIC Table 67: Rest of Asia-Pacific Current & Future Analysis for Laboratory Analytical Instruments and Consumables by End-Use - Element Analysis, Separation Analysis and Molecular Analysis - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 Table 68: Rest of Asia-Pacific Historic Review for Laboratory Analytical Instruments and Consumables by End-Use - Element Analysis, Separation Analysis and Molecular Analysis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 69: Rest of Asia-Pacific 15-Year Perspective for Laboratory Analytical Instruments and Consumables by End-Use - Percentage Breakdown of Value Sales for Element Analysis, Separation Analysis and Molecular Analysis for the Years 2012, 2020 & 2027 LATIN AMERICA Table 70: Latin America Current & Future Analysis for Laboratory Analytical Instruments and Consumables by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 Table 71: Latin America Historic Review for Laboratory Analytical Instruments and Consumables by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 72: Latin America 15-Year Perspective for Laboratory Analytical Instruments and Consumables by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2020 & 2027 Table 73: Latin America Current & Future Analysis for Laboratory Analytical Instruments and Consumables by End-Use - Element Analysis, Separation Analysis and Molecular Analysis - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 Table 74: Latin America Historic Review for Laboratory Analytical Instruments and Consumables by End-Use - Element Analysis, Separation Analysis and Molecular Analysis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 75: Latin America 15-Year Perspective for Laboratory Analytical Instruments and Consumables by End-Use - Percentage Breakdown of Value Sales for Element Analysis, Separation Analysis and Molecular Analysis for the Years 2012, 2020 & 2027 ARGENTINA Table 76: Argentina Current & Future Analysis for Laboratory Analytical Instruments and Consumables by End-Use - Element Analysis, Separation Analysis and Molecular Analysis - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 Table 77: Argentina Historic Review for Laboratory Analytical Instruments and Consumables by End-Use - Element Analysis, Separation Analysis and Molecular Analysis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 78: Argentina 15-Year Perspective for Laboratory Analytical Instruments and Consumables by End-Use - Percentage Breakdown of Value Sales for Element Analysis, Separation Analysis and Molecular Analysis for the Years 2012, 2020 & 2027 BRAZIL Table 79: Brazil Current & Future Analysis for Laboratory Analytical Instruments and Consumables by End-Use - Element Analysis, Separation Analysis and Molecular Analysis - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 Table 80: Brazil Historic Review for Laboratory Analytical Instruments and Consumables by End-Use - Element Analysis, Separation Analysis and Molecular Analysis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 81: Brazil 15-Year Perspective for Laboratory Analytical Instruments and Consumables by End-Use - Percentage Breakdown of Value Sales for Element Analysis, Separation Analysis and Molecular Analysis for the Years 2012, 2020 & 2027 MEXICO Table 82: Mexico Current & Future Analysis for Laboratory Analytical Instruments and Consumables by End-Use - Element Analysis, Separation Analysis and Molecular Analysis - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 Table 83: Mexico Historic Review for Laboratory Analytical Instruments and Consumables by End-Use - Element Analysis, Separation Analysis and Molecular Analysis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 84: Mexico 15-Year Perspective for Laboratory Analytical Instruments and Consumables by End-Use - Percentage Breakdown of Value Sales for Element Analysis, Separation Analysis and Molecular Analysis for the Years 2012, 2020 & 2027 REST OF LATIN AMERICA Table 85: Rest of Latin America Current & Future Analysis for Laboratory Analytical Instruments and Consumables by End-Use - Element Analysis, Separation Analysis and Molecular Analysis - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 Table 86: Rest of Latin America Historic Review for Laboratory Analytical Instruments and Consumables by End-Use - Element Analysis, Separation Analysis and Molecular Analysis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 87: Rest of Latin America 15-Year Perspective for Laboratory Analytical Instruments and Consumables by End-Use - Percentage Breakdown of Value Sales for Element Analysis, Separation Analysis and Molecular Analysis for the Years 2012, 2020 & 2027 MIDDLE EAST Table 88: Middle East Current & Future Analysis for Laboratory Analytical Instruments and Consumables by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 Table 89: Middle East Historic Review for Laboratory Analytical Instruments and Consumables by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 90: Middle East 15-Year Perspective for Laboratory Analytical Instruments and Consumables by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2020 & 2027 Table 91: Middle East Current & Future Analysis for Laboratory Analytical Instruments and Consumables by End-Use - Element Analysis, Separation Analysis and Molecular Analysis - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 Table 92: Middle East Historic Review for Laboratory Analytical Instruments and Consumables by End-Use - Element Analysis, Separation Analysis and Molecular Analysis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 93: Middle East 15-Year Perspective for Laboratory Analytical Instruments and Consumables by End-Use - Percentage Breakdown of Value Sales for Element Analysis, Separation Analysis and Molecular Analysis for the Years 2012, 2020 & 2027 IRAN Table 94: Iran Current & Future Analysis for Laboratory Analytical Instruments and Consumables by End-Use - Element Analysis, Separation Analysis and Molecular Analysis - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 Table 95: Iran Historic Review for Laboratory Analytical Instruments and Consumables by End-Use - Element Analysis, Separation Analysis and Molecular Analysis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 96: Iran 15-Year Perspective for Laboratory Analytical Instruments and Consumables by End-Use - Percentage Breakdown of Value Sales for Element Analysis, Separation Analysis and Molecular Analysis for the Years 2012, 2020 & 2027 ISRAEL Table 97: Israel Current & Future Analysis for Laboratory Analytical Instruments and Consumables by End-Use - Element Analysis, Separation Analysis and Molecular Analysis - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 Table 98: Israel Historic Review for Laboratory Analytical Instruments and Consumables by End-Use - Element Analysis, Separation Analysis and Molecular Analysis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 99: Israel 15-Year Perspective for Laboratory Analytical Instruments and Consumables by End-Use - Percentage Breakdown of Value Sales for Element Analysis, Separation Analysis and Molecular Analysis for the Years 2012, 2020 & 2027 SAUDI ARABIA Table 100: Saudi Arabia Current & Future Analysis for Laboratory Analytical Instruments and Consumables by End-Use - Element Analysis, Separation Analysis and Molecular Analysis - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 Table 101: Saudi Arabia Historic Review for Laboratory Analytical Instruments and Consumables by End-Use - Element Analysis, Separation Analysis and Molecular Analysis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 102: Saudi Arabia 15-Year Perspective for Laboratory Analytical Instruments and Consumables by End-Use - Percentage Breakdown of Value Sales for Element Analysis, Separation Analysis and Molecular Analysis for the Years 2012, 2020 & 2027 UNITED ARAB EMIRATES Table 103: UAE Current & Future Analysis for Laboratory Analytical Instruments and Consumables by End-Use - Element Analysis, Separation Analysis and Molecular Analysis - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 Table 104: UAE Historic Review for Laboratory Analytical Instruments and Consumables by End-Use - Element Analysis, Separation Analysis and Molecular Analysis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 105: UAE 15-Year Perspective for Laboratory Analytical Instruments and Consumables by End-Use - Percentage Breakdown of Value Sales for Element Analysis, Separation Analysis and Molecular Analysis for the Years 2012, 2020 & 2027 REST OF MIDDLE EAST Table 106: Rest of Middle East Current & Future Analysis for Laboratory Analytical Instruments and Consumables by End-Use - Element Analysis, Separation Analysis and Molecular Analysis - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 Table 107: Rest of Middle East Historic Review for Laboratory Analytical Instruments and Consumables by End-Use - Element Analysis, Separation Analysis and Molecular Analysis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 108: Rest of Middle East 15-Year Perspective for Laboratory Analytical Instruments and Consumables by End-Use - Percentage Breakdown of Value Sales for Element Analysis, Separation Analysis and Molecular Analysis for the Years 2012, 2020 & 2027 AFRICA Table 109: Africa Current & Future Analysis for Laboratory Analytical Instruments and Consumables by End-Use - Element Analysis, Separation Analysis and Molecular Analysis - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 Table 110: Africa Historic Review for Laboratory Analytical Instruments and Consumables by End-Use - Element Analysis, Separation Analysis and Molecular Analysis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 111: Africa 15-Year Perspective for Laboratory Analytical Instruments and Consumables by End-Use - Percentage Breakdown of Value Sales for Element Analysis, Separation Analysis and Molecular Analysis for the Years 2012, 2020 & 2027 IV. COMPETITION Total Companies Profiled: 38Read the full report: https://www.reportlinker.com/p05957208/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001

  • Quadient S.A: Monthly information on number of shares and voting rights

    Monthly information on number of shares and voting rights of Quadient SA In accordance with article 223.11 of Autorité des Marchés Financiers’ (French Securities and Investment board) General Regulations Ordinary shares - ISIN: FR0000120560 As at 31 January 2021Total number of shares34,562,912Theoretical total number of voting rights34,562,912Net total number of voting rights34,389,545 For more information, please contact: Laurent Sfaxi, Quadient+33 (0)1 45 36 31 39l.sfaxi@quadient.comfinancial-communication@quadient.comCaroline Baude, Quadient+33 (0)1 45 36 31 82c.baude@quadient.com Or visit our website: https://invest.quadient.com/ Attachment PDF

  • Meghan Markle Wins Legal Battle With British Tabloid Over Publication Of Letter To Her Father

    Meghan Markle, the Duchess Of Sussex, has won a dramatic legal victory against British tabloid newspaper, the Mail On Sunday, after it published a private letter she sent to her father, Thomas Markle. Per reports, Markle has secured a summary judgment in her favor from Lord Justice Warby, meaning the case is unlikely to proceed […]

  • Ad•Biotech Today

    Why don't you like this ad?

    Thank you for your feedback. We will remove this and make the necessary changes.

    These Types Of Stocks Should Be In Your Portfolio

    Finding the best biotech companies to invest in can be tricky as volatility often pockmarks the space. Clinical plans don't always come to fruiti.....

  • One in five pressured to go into workplace unnecessarily amid UK Covid crisis

    One in five pressured to go into workplace unnecessarily amid UK Covid crisis. Exclusive: Employers are putting workers at risk and increasing infections rates in communities, unions say

  • Wall Street player BNY Mellon jumps on bitcoin bandwagon

    Bitcoin and other crypto currencies took another leap towards the financial mainstream Thursday when Wall Street player BNY Mellon announced plans to accept digital currencies.

  • Loyal Dog Who Stood in the Snow and Kept Watch Over His Dead Owner Finds 'Perfect' Forever Home

    Baby Dog will now live with and provide comfort to a woman finishing up cancer treatments

  • Ad•Stansberry Research

    Why don't you like this ad?

    Thank you for your feedback. We will remove this and make the necessary changes.

    Dump Your Cash Now

    An unstoppable force is taking over our financial markets. But most Americans won’t see what’s going on until it’s too late. Here’s what’s coming.

  • AM Best Affirms Credit Ratings of ACMAT Corporation and ACSTAR Insurance Company

    AM Best has affirmed the Long-Term Issuer Credit Rating (Long-Term ICR) of "bbb" of ACMAT Corporation (ACMAT) (Farmington, CT) [OTC Market: ACMT]. Concurrently, AM Best has affirmed the Financial Strength Rating of A (Excellent) and the Long-Term ICR of "a" of ACMAT’s wholly owned subsidiary, ACSTAR Insurance Company (ACSTAR) (Chicago, IL). The outlook of these Credit Ratings (ratings) is stable.

  • Butcher guilty of murdering student Libby Squire

    Pawel Relowicz was convicted at Sheffield Crown Court of the 21-year-old’s killing in Hull in February 2019.

  • The Duke and Duchess of Cambridge team up for video chat with NHS student nurse

    We love Kate's new accessory!